We made the decision that settling was appropriate to avoid the expense and distraction of protracted litigation.
The decision to enter the settlement was made so that we could avoid the expense and the distraction that's often associated with potentially protracted litigation.
It raises awareness and encourages them to seek medical attention if they think they have a particular disease.
These studies that are referenced in the new labeling are largely updated analyses from the data that was the justification for the change in September.
It's not clear whether there's a true causal association.